(19)
(11) EP 4 251 279 A1

(12)

(43) Date of publication:
04.10.2023 Bulletin 2023/40

(21) Application number: 21827340.7

(22) Date of filing: 23.11.2021
(51) International Patent Classification (IPC): 
A61P 31/14(2006.01)
C07K 16/10(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/10; C07K 2317/76; C07K 2317/21; C07K 2317/565; C07K 2317/33; C07K 2317/732; A61K 2039/505; A61P 31/14
(86) International application number:
PCT/US2021/060631
(87) International publication number:
WO 2022/115486 (02.06.2022 Gazette 2022/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.11.2020 US 202063118474 P
02.04.2021 US 202163170342 P
21.04.2021 US 202163177724 P
10.05.2021 US 202163186779 P

(71) Applicants:
  • VIR Biotechnology, Inc.
    San Francisco, CA 94158 (US)
  • Humabs Biomed SA
    6500 Bellinzona (CH)

(72) Inventors:
  • CORTI, Davide
    6500 Bellinzona (CH)
  • PINTO, Dora
    6500 Bellinzona (CH)
  • BELTRAMELLO, Martina
    6500 Bellinzona (CH)
  • LEMPP, Florian A.
    San Francisco, CA 94158 (US)

(74) Representative: Graf von Stosch Patentanwaltsgesellschaft mbH 
Prinzregentenstraße 22
80538 München
80538 München (DE)

   


(54) ANTIBODIES THAT BIND TO MULTIPLE BETACORONAVIRUSES